• Home
  • Stocks
  • Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

View in App
1392.75 +1.80 ▲0.1%

05 June 2023, 01:40:53 PM
Volume: 85,663

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.gsk-india.com
Market Cap 23,667.72 Cr.
Enterprise Value(EV) 22,388.97 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 36.05 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 38.78 Trailing Twelve Months Ending 2023-03
Industry PE 33.43 Trailing Twelve Months Ending 2023-03
Book Value / Share 102.79 Trailing Twelve Months Ending 2023-03
Price to Book Value 13.60 Calculated using Price: 1,398.00
Dividend Yield 2.29 Period Ending 2022-03
No. of Shares Subscribed 16.94 Cr. 169,406,034 Shares
FaceValue 10
About Glaxosmithkline Pharmaceuticals Ltd.
The company is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company's Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.

Glaxosmithkline Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Glaxosmithkline Pharmaceuticals Ltd. Performance

View details >>
1 Day
+0.13%
1 Week
+6.79%
1 Month
+11.50%
3 Month
+5.13%
6 Month
+3.79%
1 Year
-7.17%
2 Year
-7.62%
5 Year
+10.25%
10 Year
+3.80%

Glaxosmithkline Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2013-12 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 24.10 24.95 18.75 16.08 17.26 21.22 4.71 17.42 18.39
Return on Capital Employed (%) 35.54 39.53 28.81 24.39 26.56 32.54 15.76 27.74 37.72
Return on Assets (%) 15.95 15.44 7.84 5.16 4.93 5.77 1.72 9.52 10.11

Glaxosmithkline Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2013-12 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 1,990 1,829 2,183 2,007 2,057 2,140 1,821 1,478 2,663 1,741
Non Curr. Liab. 159 197 3,498 3,700 2,632 2,860 180 179 159 125
Curr. Liab. 889 1,107 784 881 2,949 2,804 1,022 1,355 1,698 1,326
Minority Int.
Equity & Liab. 3,037 3,133 6,465 6,588 7,639 7,804 3,023 3,012 4,520 3,193
Non Curr. Assets 413 546 4,087 4,753 4,103 4,445 1,248 809 812 699
Curr. Assets 2,624 2,587 2,372 1,833 3,531 3,356 1,775 2,023 3,708 2,494
Misc. Exp. not W/O
Total Assets 3,037 3,133 6,465 6,588 7,639 7,804 3,023 3,012 4,520 3,193

Glaxosmithkline Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2013-12 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 2,608 3,363 2,838 2,908 2,871 3,128 3,224 2,926 3,278 3,252
Other Income 222 259 123 73 55 102 79 111 76 101
Total Income 2,830 3,622 2,961 2,982 2,926 3,230 3,303 3,036 3,354 3,352
Total Expenditure -2,124 -2,788 -2,360 -2,489 -2,366 -2,527 -2,567 -2,327 -2,516 -2,447
PBIDT 706 833 601 492 560 703 736 709 838 905
Interest 0 0 0 0 0 -1 -6 -4 -2 -2
Depreciation -20 -25 -25 -26 -38 -49 -83 -79 -68 -66
Taxation -230 -279 -202 -174 -189 -237 -213 -167 -398 -229
Exceptional Items 26 -52 2 46 18 29 -341 -173 12 -1
PAT 482 476 376 337 351 445 93 287 381 608
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 482 476 376 337 351 445 93 358 1,695 611
Adjusted EPS 28 28 22 20 21 26 6 21 100 36

Glaxosmithkline Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2012-12 Rs. Cr. 2013-12 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 314 281 338 139 234 473 409 491 578 811
Cash Fr. Inv. -110 189 180 499 301 -104 -153 -57 418 -406
Cash Fr. Finan. -441 -494 -497 -638 -511 -307 -358 -428 -696 -524
Net Change -237 -24 21 0 24 62 -102 6 300 -119
Cash & Cash Eqvt 138 114 116 115 139 201 99 105 405 286

Glaxosmithkline Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00
Public 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Glaxosmithkline Pharmaceuticals Ltd. Announcements

View details >>
Fri, 02 Jun 2023
Loss of Share Certificates
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates
Wed, 31 May 2023
Updates
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of Record Date pursuant to Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.'.
Wed, 31 May 2023
Loss of Share Certificates
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

Glaxosmithkline Pharmaceuticals Ltd. Technical Scans

View details >>
Fri, 02 Jun 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone

Glaxosmithkline Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 239,777.54 1,011.80 +1.2%
Divi's Laboratories Ltd. 93,340.08 3,466.65 -1.3%
Cipla Ltd. 77,917.34 973.00 +0.7%
Dr. Reddy's Laboratories Ltd. 76,753.53 4,616.95 +0.1%
Apollo Hospitals Enterprise Ltd. 71,422.15 4,972.65 +0.1%
Torrent Pharmaceuticals Ltd. 60,134.99 1,780.00 +0.1%
Mankind Pharma Ltd. 58,728.27 1,420.35 -3.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.30 1,011.80 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 51.54 3,466.65 -1.3%
Cipla Ltd. Consolidated 2023-03 27.85 973.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.03 4,616.95 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 87.03 4,972.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.23 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 43.99 1,420.35 -3.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.28 1,011.80 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7.36 3,466.65 -1.3%
Cipla Ltd. Consolidated 2023-03 3.33 973.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.30 4,616.95 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.52 4,972.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.65 1,420.35 -3.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,011.80 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,466.65 -1.3%
Cipla Ltd. Consolidated 2022-03 0.04 973.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,616.95 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,972.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,420.35 -3.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,011.80 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,466.65 -1.3%
Cipla Ltd. Consolidated 2022-03 13.10 973.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,616.95 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,972.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,420.35 -3.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,011.80 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,466.65 -1.3%
Cipla Ltd. Consolidated 2022-03 13.10 973.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,616.95 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,972.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,420.35 -3.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,011.80 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,466.65 -1.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 973.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,616.95 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,972.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,420.35 -3.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,011.80 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,466.65 -1.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 973.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,616.95 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,972.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,420.35 -3.1%

Glaxosmithkline Pharmaceuticals Ltd. FAQ's

What is Glaxosmithkline Phar share price?
Can I buy Glaxosmithkline Phar shares now?
What is the Dividend Yield of Glaxosmithkline Phar?
What is the Market Cap of Glaxosmithkline Phar?
What are the key metrics to analyse Glaxosmithkline Phar?
What is the 52 Week High and Low of Glaxosmithkline Phar?
What is the trend of Glaxosmithkline Phar share price?